Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.56
+1.021.47%
Post-market: 70.560.00000.00%16:10 EDT
Volume:691.01K
Turnover:48.59M
Market Cap:5.89B
PE:-115.67
High:70.84
Open:69.42
Low:69.05
Close:69.54
52wk High:90.87
52wk Low:49.38
Shares:83.46M
Float Shares:77.19M
Volume Ratio:1.00
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.61
PE(LYR):9.07

Loading ...

PTC Therapeutics schedules quarterly results webcast conference call

Reuters
·
Apr 22

PTC Therapeutics announces annual shareholder meeting notice

Reuters
·
Apr 21

BRIEF-Ptc Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 18

PTC Therapeutics grants new hire 1,155 stock options, 925 RSUs under Nasdaq rule

Reuters
·
Apr 18

Analysts’ Top Healthcare Picks: PTC Therapeutics (PTCT), PDS Biotechnology (PDSB)

TIPRANKS
·
Apr 16

PTC Therapeutics (PTCT) Receives a Buy from Raymond James

TIPRANKS
·
Apr 13

Is It Time To Reassess PTC Therapeutics (PTCT) After Its Strong One Year Rally?

Simply Wall St.
·
Apr 13

PTC Therapeutics initiated with an Outperform at Raymond James

TIPRANKS
·
Apr 10

Barclays Remains a Buy on PTC Therapeutics (PTCT)

TIPRANKS
·
Apr 09

PTC Therapeutics EVP, CLO Mark Elliott Boulding disposes of USD 101,111 common shares

Reuters
·
Apr 09

PTC Therapeutics price target lowered to $81 from $82 at RBC Capital

TIPRANKS
·
Apr 07

RBC Adjusts Price Target on PTC Therapeutics to $81 From $82, Maintains Sector Perform Rating

MT Newswires Live
·
Apr 07

Top PTC Therapeutics Executive Makes Notable Insider Stock Move

TIPRANKS
·
Apr 07

PTC Therapeutics Chief Technical Ops Officer Neil Gregory Almstead sells USD 3.6 million stock

Reuters
·
Apr 04

PTC Therapeutics Cut to Hold From Buy by Jefferies

Dow Jones
·
Mar 31

PTC Therapeutics assumed at Hold from Buy at Jefferies

TIPRANKS
·
Mar 30

A Look At PTC Therapeutics (PTCT) Valuation As Shares Reflect Mixed Recent Returns

Simply Wall St.
·
Mar 27

PTC Therapeutics files initial beneficial ownership statement; Director Jessica Caroline Chutter reports no securities beneficially owned

Reuters
·
Mar 27

PTC Therapeutics Adds Veteran Banker to Board

TIPRANKS
·
Mar 25

BRIEF-Ptc Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter To Board Of Directors

Reuters
·
Mar 25